Royalty Pharma (RPRX) stock Forecast for 2021 – 2025

Royalty Pharma (RPRX) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (05:19)

Sector: Healthcare

The share price of Royalty Pharma plc (RPRX) now

What analysts predict: $54.35

52-week high/low: $44.45 / $35.67

50/200 Day Moving Average: $41.73 / $41.3

This figure corresponds to the average price over the previous 50/200 days. For Royalty Pharma stocks, the 50-day moving average is the support level today.

For Royalty Pharma stocks, the 200-day moving average is the support level today.

Are you interested in Royalty Pharma plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Royalty Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Royalty Pharma share be worth in 2022 - 2026?

When should I take profit in Royalty Pharma stock? When should I record a loss on Royalty Pharma stock? What are analysts' forecasts for Royalty Pharma stock? What is the future of Royalty Pharma stock? We forecast Royalty Pharma stock performance using neural networks based on historical data on Royalty Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Royalty Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Royalty Pharma shares. This happens once a day.




Historical and forecast chart of Royalty Pharma stock

The chart below shows the historical price of Royalty Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Royalty Pharma stock price can be found in the table below.

Long-term forecasts by years.

Royalty Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 42.76 42.06 43.46 3.32
Nov 30 43.07 42.45 43.90 3.41
Dec 01 42.77 41.73 43.37 3.94
Dec 02 42.28 41.49 42.64 2.77
Dec 03 43.01 42.65 43.85 2.81
Dec 04 44.12 43.28 44.82 3.56
Dec 05 44.32 43.85 44.90 2.39
Dec 06 44.97 44.54 45.71 2.62
Dec 07 46.20 45.33 46.66 2.94
Dec 08 45.75 45.30 46.63 2.94
Dec 09 45.24 44.42 45.82 3.16
Dec 10 46.28 45.47 46.80 2.93
Dec 11 46.80 46.23 47.43 2.59
Dec 12 47.27 46.37 47.87 3.23
Dec 13 47.54 46.32 48.12 3.88
Dec 14 49.03 47.88 49.39 3.15
Dec 15 49.56 48.53 50.36 3.76
Dec 16 50.69 50.37 51.40 2.06
Dec 17 49.42 48.21 50.50 4.76
Dec 18 49.09 48.09 50.13 4.25
Dec 19 48.73 48.25 49.78 3.17
Dec 20 47.59 47.06 48.32 2.69
Dec 21 47.33 46.74 48.00 2.69
Dec 22 48.61 47.73 49.59 3.88
Dec 23 48.29 47.20 48.99 3.80
Dec 24 49.19 48.81 50.06 2.55
Dec 25 49.13 48.28 50.37 4.33
Dec 26 49.52 48.70 50.03 2.73
Dec 27 49.55 48.30 50.52 4.60
Dec 28 50.23 49.40 50.59 2.41

Royalty Pharma Daily Price Targets


Royalty Pharma Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $42.76.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 3.212%.
Pessimistic target level: 42.06
Optimistic target level: 43.46

Royalty Pharma Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $43.07.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 3.297%.
Pessimistic target level: 42.45
Optimistic target level: 43.90

Royalty Pharma Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $42.77.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 3.787%.
Pessimistic target level: 41.73
Optimistic target level: 43.37

Royalty Pharma Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $42.28.
Negative dynamics for Royalty Pharma shares will prevail with possible volatility of 2.697%.
Pessimistic target level: 41.49
Optimistic target level: 42.64

Royalty Pharma Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $43.01.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 2.731%.
Pessimistic target level: 42.65
Optimistic target level: 43.85

Royalty Pharma Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $44.12.
Positive dynamics for Royalty Pharma shares will prevail with possible volatility of 3.434%.
Pessimistic target level: 43.28
Optimistic target level: 44.82

RPRX (RPRX) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 44.57 43.23 45.91 5.84

Royalty Pharma forecast for this year


Royalty Pharma Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $44.5724. Pessimistic: $43.23. Optimistic: $45.91



Royalty Pharma (RPRX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 44.67 42.95 47.04 8.71
Feb 45.39 43.83 46.66 6.06
Mar 44.85 43.62 46.01 5.19
Apr 44.06 43.35 45.69 5.13
May 45.48 44.56 47.93 7.04
Jun 47.48 46.42 48.88 5.03
Jul 48.32 46.35 49.09 5.58
Aug 47.00 44.86 47.69 5.93
Sep 50.02 47.22 52.58 10.19
Oct 48.59 46.99 50.87 7.62
Nov 49.78 47.06 52.57 10.47
Dec 48.18 45.85 49.83 7.99

Royalty Pharma (RPRX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 49.89 48.11 51.71 6.96
Feb 52.72 49.92 55.57 10.16
Mar 53.54 52.45 55.56 5.60
Apr 55.11 53.30 56.65 5.92
May 53.68 51.65 55.07 6.21
Jun 55.71 54.15 57.35 5.58
Jul 54.81 53.43 57.35 6.82
Aug 53.36 51.30 55.56 7.66
Sep 53.95 52.44 54.71 4.14
Oct 54.11 51.98 56.72 8.35
Nov 57.21 55.37 59.45 6.87
Dec 56.65 55.58 58.63 5.21

Royalty Pharma (RPRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 55.62 53.24 56.67 6.05
Feb 54.14 52.97 55.09 3.85
Mar 51.30 49.07 53.13 7.64
Apr 48.42 47.75 49.27 3.10
May 49.10 47.73 51.41 7.15
Jun 46.83 45.52 48.64 6.40
Jul 46.60 45.04 47.81 5.80
Aug 48.73 47.29 50.09 5.58
Sep 50.19 47.56 52.19 8.89
Oct 49.84 48.62 50.54 3.80
Nov 49.07 47.91 50.52 5.17
Dec 50.21 49.08 51.65 4.97

Royalty Pharma (RPRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 50.28 49.50 52.95 6.51
Feb 53.76 51.54 55.49 7.12
Mar 50.19 47.59 50.92 6.55
Apr 47.55 45.49 48.62 6.44
May 47.45 45.36 49.98 9.24
Jun 48.05 46.10 49.06 6.03
Jul 50.40 49.24 52.49 6.18
Aug 53.40 50.94 54.41 6.39
Sep 53.78 52.31 55.62 5.96
Oct 56.00 53.80 57.17 5.90
Nov 54.16 51.24 55.37 7.46
Dec 53.21 51.75 55.37 6.53

Royalty Pharma information and performance

Royalty Pharma plc is a biopharmaceutical royalty purchaser and innovation sponsor for the US biopharmaceutical industry. He is also involved in identifying, evaluating and obtaining royalties for various biopharmaceuticals. In addition, the company partners with innovators from academic institutions, research hospitals and non-profit organizations, small and medium-sized biotech companies, and pharmaceutical companies.

Royalty Pharma Address

110 EAST 59TH STREET, NEW YORK, NY, US

Market Capitalization: 18 981 335 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 954 603 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 37.28

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.02

Price/earnings to growth

DPS: 0.74

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0177

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.15

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.363
Quarterly Revenue Growth YOY: -0.021
Trailing PE: 37.28

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.14

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 10.62

Enterprise Value (EV) /Revenue

EV To EBITDA: 21.84

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 441104000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Royalty Pharma (RPRX) stock dividend

Royalty Pharma last paid dividends on 11/17/2022. The next scheduled payment will be on 12/15/2022. The amount of dividends is $0.74 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.